Article: ACE inhibitors reduce mortality: So why aren't they being used?

Special Report:

ACE inhibitors reduce mortality: So why aren't they being used?

These drugs should be first-line treatment for CHF, experts say

More than 10 years after angiotensin-converting enzyme (ACE) inhibitors were first established as the drugs of choice for the treatment of congestive heart failure, recent studies show that physicians continue to seriously underuse them. And this failure to prescribe the drugs is resulting in more deaths, more hospitalizations, and a lower quality of life for countless numbers of patients, experts say.

Randall Stafford, MD, PhD, instructor in medicine at Harvard Medical School and ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!